Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

0

Number of overlapping holdings

0.0%

% of CANC's 46 holdings also in XDNA

nan%

% of XDNA's 3 holdings also in CANC

Overlap by Weight
Sector Drift (CANC minus XDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CANC
Weight
in XDNA
Overlap

Position Highlights (Non-Overlapping Exposures)
CANC Overweight Relative to XDNA
ASTRAZENECA PLC 5.5%
AMGEN INC 5.5%
REGENERON PHARMACEUTICALS 5.5%
GILEAD SCIENCES INC 4.1%
ARGENX SE ADR 4.0%
REVOLUTION MEDICINES, INC. 3.9%
ILLUMINA INC 3.8%
CHUGAI PHARMACEUTICAL CO LTD 3.5%
INCYTE CORP 3.4%
MERCK & CO. INC. 3.3%
CANC Underweight Relative to XDNA
CORBUS PHARMACEUTICALS HOLDINGS INC 0.3%
JASPER THERAPEUTICS, INC. 0.3%
ARVINAS, INC. 0.5%
ORIC PHARMACEUTICALS INC 0.5%
CG ONCOLOGY, INC. 0.5%
IMMUNOCORE HOLDINGS PLC SPONSORED AD 0.6%
TERNS PHARMACEUTICALS, INC. 0.7%
RELAY THERAPEUTICS, INC. 0.8%
CULLINAN ONCOLOGY, INC. 0.8%
IDEAYA BIOSCIENCES, INC. 0.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY